Did you know you can now get UNLIMITED CE Hours for only $74.95?
Click Here to learn more.

CE Course Description

Women who inject drugs have substantially different needs and face higher risks of disease and violence than do men who inject drugs.  This CE course seeks to illuminate the many reasons a focus on drug-injecting women is important, including their significantly higher mortality rates, increased likelihood of facing injecting-related problems, faster progression from first use to dependence, higher rates of HIV, increased risky injection and/or sexual risk behaviors.

Article Author:  Anna Roberts LL.B, MIPH, et al.
Exam writer:  Patricia Hocking-Walker, M.S. (Psychology)

CE Course Objectives

1.  Investigate predictors for initiation into injecting drug use.

2.  Compare and contrast residential, outpatient, and low threshold treatment designs.

3.  Examine the primary source of risk that may explain the higher rates of HIV among female IDU sex workers.

4.  Elucidate one of the strongest individual attribute predictors of initiating to injecting.

5.  Identify when female IDU are more likely to enter and remain in treatment.

6.  Provide the main structural barrier to seeking treatment.

ACE credit is not offered for this course. A list of courses offering ACE credit can be found here.

CAADE Approval

This course is CAADE approved.

Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degrees of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.

*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at support@quantumunitsed.com.

Added On: 08/09/2017